Pharma Tech Outlook: Pharma Tech Magazine

NAMSA: Advancing Global Patient Healthcare Through Full Continuum CRO Services For Medical Device Sponsors

Top 10 CRO - 2020


Contract research organizations (CRO) are playing a significant role in helping the biopharmaceutical industry reduce the risk and cost associated with clinical drug development. Traditionally, CROs were generally considered only for clinical trials and lab services. However, the CRO market has evolved today to cover data and analytics for drug trial insights and design, drug development planning, medical affairs, and regulatory consulting. The escalating demand for pharmacovigilance and safety, clinical trial feasibility, and protocol optimization have also been instrumental in the growth of the CRO industry.

Today, the industry is undergoing a significant transformation as the CROs increasingly recognize the benefits of e-clinical technologies that allow precise, faster, trackable, and more productive studies. The application of advanced technology and analytics is creating a new pool of opportunities for improving trial performance by bringing forth cutting-edge approaches for trial designs, site selections, and patient recruitments. For instance, big data and blockchain are enabling CROs to optimize data quality and adopt a unified approach for capturing and storing data. Besides, virtual clinical trials are enabling CROs to be more effective and patient-centric as it allows them to create a personalized approach that reduces the burden on patients. These radical advancements allow CROs to access new compounds and resources and bring profound changes in their existing nomenclature of clinical trials. CROs are implementing platforms that improve the performance of clinical trials, control and share data, track and report trial outcomes, and manage regulatory information while cutting the costs.

The continued expansion on the scope of offerings from CROs will appeal to companies that choose to outsource a significant portion of their research and development for improving operational efficiency and driving meaningful cost savings. At this juncture, there is a wide variety of CROs entering the industry with a set of advanced and integrated offerings. To help companies strengthen their healthcare capabilities and simultaneously enable growth in the industry, Pharma Tech Outlook has compiled a list of the top 10 CROs. The list comprises prominent organizations in the industry that solve healthcare challenges by implementing the current trends in the space. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for the aspiring CIOs.

We present to you Pharma Tech Outlook’s “Top 10 CROs – 2020.”

    Top CRO Companies

  • As a Pennsylvania-based full-service nonclinical CRO, Absorption Systems provides innovative services and solutions for the pharmaceutical, biotech, medical device, and regenerative medicine industry. With a heavy focus in analytical testing, whether for unique therapies yet to be accepted or for early stages of launching a new product, the company develops test systems that can be validated to help characterize cell and gene therapy products to meet the requirements for stability and relief therapy. To understand a product’s ability to work upon giving it to the patients, Absorption Systems analytically tests its potency outside of humans. The company’s unparalleled knowledge and expertise have been instrumental in the regulatory approvals of numerous unique therapies over its 25-year history

  • ACD, a Bio-Techne brand, expands research tools for spatial genomics by combining molecular information with spatial context in one simple assay. The company provides a powerful new tool for visualizing and quantifying modified cells and genes in tissue through RNAscopeTM, an advanced in situ hybridization (ISH) technology. ACD is rapidly becoming established as the leader in the C> space due to its novel method of tracking the bio-distribution of genetically modified cells in the tissue. At ACD, the Pharma Assay Services group has years of experience designing and executing studies for dozens of C> companies. Researchers who partner with Pharma Assay Services will receive on-demand access to the most specialized and technically experienced RNAscope hands of any CRO

  • AIT Bioscience is an integrated contract research laboratory that offers continuous process monitoring and real-time quality control processes in Ligand Binding Assay (LBA) bioanalytics for large molecules, alongside traditional and high-resolution LC-MS/MS bioanalytics for small molecules in preclinical and Phase I – III clinical trials. The company’s custom-built facility in Indianapolis, near one of the largest life sciences sample management hubs in the United States, houses a collaborative team of LC-MS and LBA scientists equipped with everything necessary to generate the data clients need

  • Specializing in personal and customized preclinical contract research, Biomere is a preclinical CRO based in Worcester, MA that offers an extensive portfolio of discovery and development services from proof-of-concept, pharmacology and surgical models to safety testing for the biomedical industry. What differentiates or sets Biomere apart is the uniqueness of service which stems from the cornerstone of who they are--At Biomere, it’s personal. Committed to delivering discovery-based services, the CRO draws on its rich expertise of industry veterans across a variety of therapeutic areas to ensure that the services are personalized and customized to each client’s specific requirements. The team of experts at Biomere fosters personal relationships with sponsors and works in close collaboration with them to deliver the highest quality services. Furthermore, clients are also empowered with the utmost flexibility and adaptability in their discovery

  • Clinilabs Drug Development Corporation has emerged as a specialty CRO that has set a new standard for best practices in CNS drug development. As the only global full-service CRO exclusively focused on the development of neurotherapeutics, Clinilabs brings to bear its rich expertise, experience, and knowledge in developing new drugs for psychiatric disorders, neurological disorders, and substance use disorders. The company has specialized knowledge in the field of CNS therapeutics, a strong understanding of the patient populations in need, and the knowhow to implement the protocols and study designs

  • Frontage Laboratories is a CRO that provides integrated, science-driven product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Leveraging its strong scientific and management expertise, the company is committed to providing the highest quality for each project. Over 70 percent of the company’s scientific staff have advanced degrees. The team provides clients the required knowledge on utilizing novel pharma tools in the most creative way to help companies deal with complex challenges such as issues in drug formulation, bioanalysis and data interpretation

  • Helping medical device Sponsors improve healthcare since 1967, NAMSA is the only 100% medical device-focused, full continuum Contract Research Organization (CRO) in the world. Driven by our global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, we are the industry’s premier, trusted partner for successful development and commercialization outcomes

  • PsychoGenics is a preclinical CRO dedicated to discovering the next generation of breakthrough treatments for severely disabling neuropsychiatric disorders and life threatening orphan diseases. The company offers broad capabilities and disease models in many CNS therapeutic areas, including Alzheimer’s disease, Parkinson’s disease, depression, schizophrenia, pain, and autism spectrum disorders

  • TKL Research, Inc. is a 75-year old full-service CRO. Successfully catering to the pharmaceutical, biotechnology, medical device, and consumer healthcare industries since its inception, TKL firmly stands as one of the pre-eminent CROs in the country. TKL is an integrated network of clinical research centers consisting of a 40-bed pharmacology unit and four outpatient clinics in the NY/NJ metro area. Combining this unique structure with TKL’s seasoned professional staff gives you one of the industry’s most experienced, focused, and flexible CROs

  • Wake Research

    Wake Research

    Wake Research is an organization of unified investigational sites working closely with and meeting the needs of the global bio-pharmaceutical, biotechnology, medical device, pharmaceutical industry, and clinical research organizations. The company orchestrates a wide variety of trial studies suitable for a diverse pool of therapeutic areas, including Dermatology, Women’s Health, Neurology, Crohn’s Disease, Ulcerative Colitis, Irritable Bowel Syndrome, and Cancer. Conducting clinical studies since 1984, Wake Research has its own proprietary patient database of more than 2 million potential clinical trial participants, including people across all ages and ethnicities. The company’s physician network consists of more than 1000 physicians, 100 key opinion leaders, and principal investigators, all committed to patient-centric care